Ep. 122: “IMMUNOLOGY2026™” Featuring Drs. Ulrich von Andrian and Shekhar Pasare

Guests:

Dr. Ulrich von Andrian is the Mallinckrodt Professor of Immunopathology at Harvard Medical School and President of the American Association of Immunologists (AAI). Dr. Shekhar Pasare is Professor and Director of the Division of Immunobiology at Cincinnati Children’s Hospital Medical Center. He is also the Program Committee Chair for the AAI’s annual meetings. They discuss the upcoming IMMUNOLOGY2026 meeting taking place April 15-19 in Boston. They cover highlights of the program including the Presidential Symposium, special sessions, and opportunities for trainees. (42:30)

Featured Products and Resources:

• Submit a late-breaking abstract for IMMUNOLOGY2026!
• Wallchart: T Cell Nomenclature: From Subsets to Modules

The Immunology Science Round Up

Psoriatic Arthritis – A two-step process involving skin-derived myeloid precursors and joint-resident fibroblasts orchestrates the spread of inflammation from the skin to the joints. (6:15)

Chemotherapy and Cardiac-Resident Macrophages – DNA-damaging chemotherapy can reshape cardiac macrophage ontogeny. (13:50)

Dendritic Cell Cross-Presentation – Neoantigen cross-presentation by Type 1 conventional dendritic cells can determine the immune visibility of the tumor mutational landscape. (26:00)

T Cell Cross-Reactivity – Co-receptor switching generates super selective T cells that reduce the risk of lethal off-target cross-reactivity. (32:20)

Images courtesy of Drs. Ulrich von Andrian and Shekhar Pasare

Subscribe to our newsletter!

Never miss updates about new episodes.

Subscribe